Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Zelnorm Returning To US Market With Broad IBS-C Indication

Apr 02 2019

• By Michael Cipriano

The Photo Of Large Intestine Is On The Woman's Body. People With Stomach Ache Problem Concept. Female Anatomy

Related Content

US FDA Seems Ready For Return Of Zelnorm, But Seeks Advice On Best Subpopulation

Oct 17 2018

Zelnorm's Return: US FDA Panel Hands Down Split Decision On Constipation Drug's Target Population

Oct 18 2018

Keeping Track: AstraZeneca Wins Approval For Lumoxiti, AbbVie Expands Label For Venclexta With MRD Data, and FDA Delays Acorda's Inbrijia NDA

Sep 17 2018

Door Open For Zelnorm Return Despite Marketing “Suspension,” Novartis Says

Apr 02 2007

Related Companies

US WorldMeds, LLC

Novartis AG

Mallinckrodt plc

Allergan plc

Synergy Pharmaceuticals, Inc.

Ardelyx Inc.

Additional Topics

United States Approvals Drug Safety Regulation Gastrointestinal BioPharmaceutical

More from Approvals

More from Product Reviews

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.